BLFS logo
BLFS NASDAQ US

BioLife Solutions, Inc. - Common Stock

Healthcare · Life Sciences Tools & Services Situs Web · IPO Nov 1989
$19,51
▲ +$0,22 (+1,14%)
Vol 209K
5
Skor Kualitas
fail
Kap. Pasar
$1.2B
ROE
-0,9%
Margin
-20,2%
D/E
2,12
Beta
1,93
52W
$19–$30

Konsensus Wall Street

16 analis · Apr 2026
4
Beli Kuat
11
Beli
1
Tahan
0
Jual
0
Jual Kuat
93,8%
Peringkat Beli

Grafik Harga

Saham Serupa

SHC
Sotera Health Co
P/E 90,4
$5.0B
TXG
10X Genomics Inc
$2.1B
ADPT
Adaptive Biotechnologies Corp
$2.5B
AZTA
Azenta Inc
$1.5B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7,1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M

Pendapatan

Tingkat beat: 100,0%
Laporan Berikutnya Mei 06, 2026
Estimasi EPS: $0,02
Kuartal EPS Estimasi EPS Aktual Kejutan
Mar 2026 $0,02 — —
Des 2025 $-0,02 $0,22 +$0,24
Sep 2025 $-0,01 $0,01 +$0,02
Jun 2025 $-0,04 $-0,01 +$0,03

Pendapatan & Laba Kuartalan

Kuartal 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Pendapatan — -$3.4M $23.9M $25.4M $28.1M $18.8M
Laba Bersih — $12.5M -$448K -$15.8M $621K $11.1M

Tren Fundamental

Metrik 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -1.6% -1.6% -1.6% -1.6% -0.9% -0.9%
P/E (TTM) — — — — — —
Net Margin -62.3% -22.5% -22.5% -22.5% -20.2% -20.2%
Gross Margin 64.6% 60.7% 60.7% 60.7% 64.8% 64.8%
D/E Ratio 2.90 2.90 2.90 2.90 2.12 2.12
Current Ratio 4.43 4.43 4.43 4.43 4.66 4.66

Rasio Utama

ROA (TTM)
-0,8%
P/S (TTM)
15,73
P/B
3,4
EPS (TTM)
$-0,06
CF/Share
$-2,09
Pertumbuhan Pendapatan 3T
-11,6%
52W High
$29,62
52W Low
$19,10
$19,10 Rentang 52 Minggu $29,62

Kesehatan Keuangan

Arus Kas Bebas
-$9.6M
Utang Bersih
-$15.1M
Kas
$33.0M
Total Utang
$17.9M
Per tanggal Des 31, 2025

Як BLFS виглядає на тлі конкурентів у Life Sciences Tools & Services?

Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній

BLFS ABCL ADPT AZTA BRKR

Оцінка BLFS vs аналоги Life Sciences Tools & Services

P/E
—
▼ 0% di bawah rekan (32,5)
vs Rekan
vs Industri
Nilai wajar
P/S
15,7
▲ 312% di atas rekan (3,8)
vs Rekan
vs Industri
Overvalued
P/B
3,4
▼ 8% di bawah rekan (3,7)
vs Rekan
vs Industri
Nilai wajar
Дивідендна дохідність
—
▼ 0% di bawah rekan (0,5%)
vs Rekan
vs Industri
Yield rendah

Прибутковість BLFS vs аналоги Life Sciences Tools & Services

ROE
-0,9%
▲ 72% di atas rekan (-3,3%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-20,2%
▼ 115% di bawah rekan (-9,4%)
vs Rekan
vs Industri
Lemah
Валова маржа
64,8%
▲ 35% di atas rekan (48,0%)
vs Rekan
vs Industri
Tingkat atas
ROA
-0,8%
▲ 69% di atas rekan (-2,6%)
vs Rekan
vs Industri
Di bawah rata-rata

Фінансове здоровʼя BLFS vs аналоги Life Sciences Tools & Services

D/E ratio
2,1
▼ 94% di bawah rekan (36,5)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
4,7
▲ 38% di atas rekan (3,4)
vs Rekan
vs Industri
Likuiditas kuat
Beta
1,9
▲ 36% di atas rekan (1,4)
vs Rekan
vs Industri
Lebih volatil

Радар фундаменталів BLFS

BLFS Median rekan Industri

BLFS прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

BLFS vs аналоги: ключові метрики

Aktivitas Orang Dalam

Neutral
Pembelian
0
Penjualan
0
FOSTER KAREN A
Chief Operating Officer · Mar 09
97423 shs
BERARD TODD C.J.
Officer · Mar 03
353 shs
MATHEW ABY J
Officer · Mar 03
529 shs
WICHTERMAN TROY
Chief Financial Officer · Mar 03
588 shs
WERNER SEAN
Chief Technology Officer · Mar 03
111 shs
FOSTER KAREN A
Officer · Mar 03
418 shs
AEBERSOLD SARAH
Officer · Mar 03
219 shs
WICHTERMAN TROY
Chief Financial Officer · Feb 24
96016 shs
WERNER SEAN
Chief Technology Officer · Feb 24
24116 shs
DE GREEF RODERICK
Chief Executive Officer · Feb 24
508045 shs
Terakhir 90 hari

Pemegang Terbesar

Top 5: 49,83%
Casdin Capital, LLC
12,33%
$110.7M
Blackrock Inc.
12,24%
$109.9M
T. Rowe Price Investment Ma…
10,73%
$96.3M
Invesco Ltd.
8,14%
$73.1M
Vanguard Group Inc
6,39%
$57.4M
Per tanggal Des 31, 2025

Berita Terbaru

Belum ada berita terkait